Barclays’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.7M | Buy |
1,632,615
+703,796
| +76% | +$33.1M | 0.02% | 418 |
|
|
2025
Q1 | $41M | Buy |
928,819
+772,696
| +495% | +$34.1M | 0.01% | 545 |
|
|
2024
Q4 | $5.64M | Buy |
156,123
+447
| +0.3% | +$16.2K | ﹤0.01% | 1496 |
|
|
2024
Q3 | $4.99M | Buy |
155,676
+58,645
| +60% | +$1.88M | ﹤0.01% | 1537 |
|
|
2024
Q2 | $3.65M | Buy |
97,031
+24,252
| +33% | +$913K | ﹤0.01% | 1334 |
|
|
2024
Q1 | $3.58M | Sell |
72,779
-81,494
| -53% | -$4.01M | ﹤0.01% | 1544 |
|
|
2023
Q4 | $5.63M | Buy |
154,273
+56,357
| +58% | +$2.06M | ﹤0.01% | 1404 |
|
|
2023
Q3 | $2.27M | Sell |
97,916
-23,844
| -20% | -$552K | ﹤0.01% | 1596 |
|
|
2023
Q2 | $3.19M | Sell |
121,760
-536,105
| -81% | -$14.1M | ﹤0.01% | 1469 |
|
|
2023
Q1 | $16.9M | Sell |
657,865
-317,947
| -33% | -$8.18M | 0.01% | 637 |
|
|
2022
Q4 | $25.4M | Buy |
975,812
+823,439
| +540% | +$21.4M | 0.01% | 571 |
|
|
2022
Q3 | $4.35M | Buy |
152,373
+139,337
| +1,069% | +$3.98M | ﹤0.01% | 1178 |
|
|
2022
Q2 | $321K | Sell |
13,036
-13,896
| -52% | -$342K | ﹤0.01% | 2860 |
|
|
2022
Q1 | $1.52M | Buy |
+26,932
| New | +$1.52M | ﹤0.01% | 1991 |
|